Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Zillow To Acquire StreetEasy For $50 Mln In Cash - Quick Facts

RELATED NEWS
Trade Z now with 

Zillow Inc. (Z: Quote), the largest U.S. real estate and home-related marketplace, announced that it has entered into a definitive agreement to acquire StreetEasy, real estate website in New York City, for $50 million in cash. The transaction is subject to satisfaction of customary closing conditions and is expected to close in the next few weeks.

StreetEasy attracts nearly 1.2 million monthly unique users, primarily home shoppers in the New York region.

StreetEasy launched in 2006 and has 34 employees. StreetEasy provides for-sale and for-rent listings through partnerships with all of the largest real estate brokerages in New York.

Click here to receive FREE breaking news email alerts for Zillow, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.